Paissoni C, Puri S, Broggini L, Sriramoju M, Maritan M, Russo R
Elife. 2025; 13.
PMID: 40028903
PMC: 11875538.
DOI: 10.7554/eLife.102002.
Yu Y, Li Z, Li G, Wang T, Li Y
BMC Cardiovasc Disord. 2025; 25(1):1.
PMID: 39748274
PMC: 11694375.
DOI: 10.1186/s12872-024-04441-6.
Mohammad Karim A
Pharmaceutics. 2024; 16(11).
PMID: 39598565
PMC: 11597675.
DOI: 10.3390/pharmaceutics16111442.
Morgan G, Yung Z, Spencer B, Sanchorawala V, Prokaeva T
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598451
PMC: 11597191.
DOI: 10.3390/ph17111542.
Sheehan K, Jeon H, Corr S, Hayes J, Mok K
Protein J. 2024; 44(1):1-20.
PMID: 39527351
DOI: 10.1007/s10930-024-10237-6.
Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosis.
Karimi-Farsijani S, Sharma K, Ugrina M, Kuhn L, Pfeiffer P, Haupt C
Nat Commun. 2024; 15(1):9648.
PMID: 39511224
PMC: 11543692.
DOI: 10.1038/s41467-024-54091-7.
Conformational Differences in the Light Chain Constant Domain of Immunoglobulin G and Free Light Chain May Influence Proteolysis in AL Amyloidosis.
Klimtchuk E, Prokaeva T, Spencer B, Wong S, Ghosh S, Urdaneta A
J Mol Biol. 2024; 436(23):168837.
PMID: 39490919
PMC: 11636358.
DOI: 10.1016/j.jmb.2024.168837.
Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis.
Schulte T, Chaves-Sanjuan A, Speranzini V, Sicking K, Milazzo M, Mazzini G
Nat Commun. 2024; 15(1):6359.
PMID: 39069558
PMC: 11284220.
DOI: 10.1038/s41467-024-50686-2.
Molecular basis for non-invasive diagnostics of cardiac amyloids using bone tracers.
Lewkowicz E, Jayaraman S, Gursky O
Biomater Sci. 2024; 12(17):4275-4282.
PMID: 39046441
PMC: 11334954.
DOI: 10.1039/d4bm00816b.
Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis.
Karimi-Farsijani S, Pfeiffer P, Banerjee S, Baur J, Kuhn L, Kupfer N
Nat Commun. 2024; 15(1):5121.
PMID: 38879609
PMC: 11180120.
DOI: 10.1038/s41467-024-49520-6.
Molecular Crowding: The History and Development of a Scientific Paradigm.
Alfano C, Fichou Y, Huber K, Weiss M, Spruijt E, Ebbinghaus S
Chem Rev. 2024; 124(6):3186-3219.
PMID: 38466779
PMC: 10979406.
DOI: 10.1021/acs.chemrev.3c00615.
Post-translational modification sites are present in hydrophilic cavities of alpha-synuclein, tau, FUS, and TDP-43 fibrils: A molecular dynamics study.
Kochen N, Seaney D, Vasandani V, Murray M, Braun A, Sachs J
Proteins. 2024; 92(7):854-864.
PMID: 38458997
PMC: 11147710.
DOI: 10.1002/prot.26679.
Re-Engineering Therapeutic Anti-Aβ Monoclonal Antibody to Target Amyloid Light Chain.
Bai J, Li X, Zhao J, Zong H, Yuan Y, Wang L
Int J Mol Sci. 2024; 25(3).
PMID: 38338870
PMC: 10855199.
DOI: 10.3390/ijms25031593.
Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid.
Aubrey L, Ninkina N, Ulamec S, Abramycheva N, Vasili E, Devine O
Proc Natl Acad Sci U S A. 2024; 121(2):e2309700120.
PMID: 38170745
PMC: 10786281.
DOI: 10.1073/pnas.2309700120.
Competition between inside-out unfolding and pathogenic aggregation in an amyloid-forming β-propeller.
Saccuzzo E, Mebrat M, Scelsi H, Kim M, Ma M, Su X
Nat Commun. 2024; 15(1):155.
PMID: 38168102
PMC: 10762032.
DOI: 10.1038/s41467-023-44479-2.
Kinetic evidence for multiple aggregation pathways in antibody light chain variable domains.
Wong S, West M, Morgan G
Protein Sci. 2023; 33(3):e4871.
PMID: 38100259
PMC: 10868443.
DOI: 10.1002/pro.4871.
Structural basis of insulin fibrillation.
Wang L, Hall C, Uchikawa E, Chen D, Choi E, Zhang X
Sci Adv. 2023; 9(37):eadi1057.
PMID: 37713485
PMC: 10881025.
DOI: 10.1126/sciadv.adi1057.
Mechanisms and pathology of protein misfolding and aggregation.
Louros N, Schymkowitz J, Rousseau F
Nat Rev Mol Cell Biol. 2023; 24(12):912-933.
PMID: 37684425
DOI: 10.1038/s41580-023-00647-2.
Role of the mechanisms for antibody repertoire diversification in monoclonal light chain deposition disorders: when a friend becomes foe.
Del Pozo-Yauner L, Herrera G, Perez Carreon J, Turbat-Herrera E, Rodriguez-Alvarez F, Ruiz Zamora R
Front Immunol. 2023; 14:1203425.
PMID: 37520549
PMC: 10374031.
DOI: 10.3389/fimmu.2023.1203425.
Role of complementarity-determining regions 1 and 3 in pathologic amyloid formation by human immunoglobulin κ1 light chains.
Klimtchuk E, Peterle D, Bullitt E, Connors L, Engen J, Gursky O
Amyloid. 2023; 30(4):364-378.
PMID: 37216473
PMC: 10663386.
DOI: 10.1080/13506129.2023.2212397.